Cue biopharma to present at the upcoming jmp securities life sciences conference

Boston, may 08, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific t cells directly within the patient's body, announced today that it will take part in a fireside chat at the jmp securities life sciences conference being held at the new york hilton midtown, may 15-16, 2023.
CUE Ratings Summary
CUE Quant Ranking